视网膜母细胞瘤动脉内化疗期间的辐射剂量降低:对96次连续儿科介入操作使用五种不同方案的回顾性分析
该单中心回顾性研究纳入24例视网膜母细胞瘤患儿共96次动脉内化疗介入,按五种影像方案分类,评估辐射暴露。结果显示氟透视时间和空气比释动能随时间下降,最终季度全部采用E方案,较第一四分位分别降低66.7%和94.1%,技术成功率和安全性未受影响。
要点
- 视网膜母细胞瘤患儿对电离辐射敏感,介入操作中应关注辐射剂量。
- 取消序列、将双平面成像简化为仅侧位成像、以路图血管造影替代数字减影血管造影可大幅降低辐射。
- E方案较A方案平均空气比释动能明显降低(5.4 mGy vs 118.2 mGy)。
核心结论
- 取消序列、将双平面成像整合为仅侧位成像、以路图血管造影替代数字减影血管造影,可显著降低视网膜母细胞瘤动脉内化疗期间的辐射暴露,且未对技术成功或安全性产生不良影响。
研究设计与样本
- 单中心回顾性分析,纳入2014年5月至2020年5月(72个月)连续24例视网膜母细胞瘤患儿,平均年龄30.8±16.3个月(范围3.2-83.4个月),无排除病例。
- 共96次连续介入操作、109次眼部治疗,其中13次(15.5%)为双侧治疗。
- 主要结局为辐射暴露,次要结局为技术成功和操作不良事件;技术成功定义为插管至眼动脉或脑膜泪腺动脉并完成化疗药物输注。
- 每次操作回顾性归类为五种影像方案之一,方案特征包括单平面与多平面成像、数字减影血管造影与路图血管造影技术。
诊断标准与关键数值
- 眼部技术成功率为106/109(97.2%),3次治疗失败均在一周内成功重复。
- 96次操作中方案A、B、C、D、E分别占10次(10.4%)、9次(9.4%)、13次(13.5%)、28次(29.2%)和36次(37.5%)。
- 方案A平均氟透视时间10.3±6.8分钟(范围3.0-25.4分钟),平均空气比释动能118.2±61.2 mGy(范围24.5-167.3 mGy)。
- 方案E平均氟透视时间3.1±3.2分钟(范围0.7-15.1分钟),平均空气比释动能5.4±4.2 mGy(范围1.4-19.5 mGy)。
- 总体平均氟透视时间6.4±6.2分钟(范围0.7-31.1分钟),平均空气比释动能36.2±52.2 mGy(范围1.4-215.0 mGy)。
临床应用与阅片要点
- 第一四分位(第1-24次操作)中方案A、B、C、D、E分别占8次(33.3%)、7次(29.2%)、2次(8.3%)、6次(25.0%)和1次(4.2%),平均氟透视时间10.5±8.2分钟(范围2.4-28.1分钟),平均空气比释动能84.2±71.6 mGy(范围12.8-215.0 mGy)。
- 最终四分位(第73-96次操作)全部24次(100%)采用方案E,平均氟透视时间3.5±4.0分钟(范围0.7-15.1分钟),平均空气比释动能5.0±4.3 mGy(范围1.4-18.0 mGy),较第一四分位分别降低66.7%和94.1%。
- 后半程操作技术成功率为100%。
- 共发生2例(1.8%)主要并发症和4例(3.7%)次要并发症。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Intra-arterial chemotherapy (IAC) represents a mainstay of retinoblastoma treatment in children. Patients with retinoblastoma are uniquely at risk for secondary malignancies and are sensitive to the ionizing effects of radiation.
OBJECTIVE: To retrospectively review a single institution's experience with IAC for retinoblastoma and the effect of variable intra-procedural imaging techniques on radiation exposure.
MATERIALS AND METHODS: Twenty-four consecutive patients, with a mean age of 30.8±16.3 months (range: 3.2-83.4 months), undergoing IAC for retinoblastoma between May 2014 and May 2020 (72 months) were included. No patients were excluded. The primary outcome was radiation exposure and secondary outcomes included technical success and procedural adverse events. Technical success was defined as catheterization of the ophthalmic or meningolacrimal artery and complete delivery of chemotherapy. Each procedure was retrospectively reviewed and categorized as one of five imaging protocol types. Protocol types were characterized by uniplanar versus multiplanar imaging and digital subtraction angiographic versus roadmap angiographic techniques. Radiation exposure, protocol utilization, the association of protocol and radiation exposure were assessed.
RESULTS: During 96 consecutive interventions, 109 ocular treatments were performed. Thirteen of the 96 (15.5%) treatments were bilateral. Ocular technical success was 106 of 109 (97.2%). All three treatment failures were successfully repeated within a week. Mean fluoroscopy time was 6.4±6.2 min (range: 0.7-31.1 min). Mean air kerma was 36.2±52.2 mGy (range: 1.4-215.0 mGy). There were two major (1.8%) complications and four (3.7%) minor complications. Of the 96 procedures, 10 (10.4%), 9 (9.4%), 13 (13.5%), 28 (29.2%) and 36 (37.5%) were performed using protocol types A, B, C, D and E, respectively. For protocol type A, mean fluoroscopy time was 10.3±6.8 min (range: 3.0-25.4 min) and mean air kerma was 118.2±61.2 mGy (range: 24.5-167.3 mGy). For protocol type E, mean fluoroscopy time was 3.1±3.2 min (range: 0.7-15.1 min) and mean air kerma was 5.4±4.2 mGy (range: 1.4-19.5 mGy). Fluoroscopy time and air kerma decreased over time, corresponding to the reduced use of multiplanar imaging and digital subtraction angiography. In the first quartile (procedures 1-24), 8 (33.3%), 7 (29.2%), 2 (8.3%), 6 (25.0%) and 1 (4.2%) were performed using protocol types A, B, C, D and E, respectively. Mean fluoroscopy time was 10.5±8.2 min (range: 2.4-28.1 min) and mean air kerma was 84.2±71.6 mGy (range: 12.8-215.0 mGy). In the final quartile (procedures 73-96), 24 (100%) procedures were performed using protocol type E. Mean fluoroscopy time was 3.5±4.0 min (range: 0.7-15.1 min) and mean air kerma was 5.0±4.3 mGy (range: 1.4-18.0 mGy), representing 66.7% and 94.1% reductions from the first quartile, respectively. Technical success in the second half of the experience was 100%.
CONCLUSION: Sequence elimination, consolidation from biplane imaging to lateral-only imaging, and replacing digital subtraction with roadmap angiography dramatically reduced radiation exposure during IAC for retinoblastoma without adversely affecting technical success or safety.
引用
- Monroe EJ, Chick JFB, Stacey AW, et al. Radiation dose reduction during intra-arterial chemotherapy for retinoblastoma: a retrospective analysis of 96 consecutive pediatric interventions using five distinct protocols. Pediatr Radiol. 2020. PMID: 33231717. doi:10.1007/s00247-020-04892-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。